This site is intended for healthcare professionals only
LoginRegister
Sun Pharma Gets CDSCO Panel Nod to Conduct Active Post-Marketing Study for Antacid Combination TabletSun Pharma's Dapagliflozin, Glimepiride, Metformin FDC Fails to Secure CDSCO Panel Nod Over Safety,...
CDSCO Panel Asks Pure and Cure Healthcare To Revise Phase III Protocol of Tapinarof CreamSubmit BE Raw Data, Interaction Study on Dapagliflozin-Rosuvastatin FDC: Expert Panel Tells Pure and...
Evotec gets USD 5 m milestone payment from Bristol Myers SquibbBristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab...
Alembic Pharma bags USFDA nod for erosive esophagitis drug Dexlansoprazole Delayed ReleaseAlembic Pharma wins USFDA approval for pulmonary arterial hypertension drug Macitentan
Merck bags European Commission nod for subcutaneous administration of Keytruda for all adult indications approved in EUMerck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for...
Boehringer Ingelheim, Palatin Technologies to develop melanocortin receptor targeted treatment for retinal diseasesBoehringer Ingelheim, Palatin Technologies to develop melanocortin receptor targeted treatment for...
Alembic Pharma gets USFDA nod for angina drug Diltiazem HydrochlorideUSFDA approves Tonix Pharma Tonmya for fibromyalgia in adults
Zydus Amplitude receives CE mark for robotic surgical system AndyRegulatory Roadblock for Zydus: CDSCO Panel Halts MMRV Vaccine Trial, Seeks Adult Data
Expert Panel Rejects Zuventus Trelagliptin PMS Plan, Seeks Higher Patient EnrolmentExpert Panel Rejects Zuventus' Trelagliptin PMS Plan, Seeks Higher Patient Enrolment
Roche Lunsumio subcutaneous secures European Commission approval for refractory follicular lymphomaMarksans Pharma UK arm gets MHRA nod for Metformin Hydrochloride Relonchem Prolonged Release Tablets...
Bayer Hyrnuo secures USFDA accelerated approval for previously treated advanced HER2 mutant non small cell lung cancerBayer Gets CDSCO Committee Nod to Manufacture, Market Darolutamide 300 mg for mHSPC, PMS Study...
Aurobindo Pharma China Plant incurring loss, break even expected by Q4Aurobindo Pharma ramps up China facility production, eyes Q3 FY26 break even
X